Evolution Mining share price jumps to A$15.02 as gold snaps back; ASX:EVN traders eye Feb 11 results
4 February 2026
2 mins read

Evolution Mining share price jumps to A$15.02 as gold snaps back; ASX:EVN traders eye Feb 11 results

Sydney, Feb 4, 2026, 17:22 AEDT — After-hours

  • Evolution Mining shares rose 3.9% on Wednesday, pushing their rally into a second day.
  • Gold rose once more, with investors flocking to safe havens and boosting bullion-focused miners.
  • Attention shifts to the miner’s half-year results on Feb. 11, along with any updates on costs and future guidance.

Evolution Mining’s shares climbed 3.9% to A$15.02 by Wednesday’s close, pushing the stock up roughly 8% over the last two trading days following a steep drop earlier in the week. (Intelligent Investor)

This is significant since the stock has been moving like a high-beta play on gold, which itself has been volatile amid geopolitical news and shifting policy expectations. The real challenge comes next week, when the miner must prove it can support a higher share price with solid earnings and stable expenses.

Gold pushed higher again on Wednesday, with spot prices rising 2.7% to $5,071.79 an ounce following a 5.9% surge the day before. The spike came as tensions between the U.S. and Iran intensified, driving investors back to safe-haven assets. “Gold has climbed back about the key $5,000 level,” said Jigar Trivedi at IndusInd Securities, highlighting the metal’s renewed allure after U.S. forces shot down an Iranian drone. Talks are expected to take place in Oman on Friday. (Reuters)

The day before, bargain hunters sparked a sharp rebound following two days of selling, driving spot gold up 5.2% to $4,906.82 an ounce by early New York afternoon. Peter Grant, vice president and senior metals strategist at Zaner Metals, called the recent losses “corrective within the long-term uptrend,” highlighting $4,400 as key support and resistance near $5,100. (Reuters)

Monday brought a wild ride for gold. Spot gold dropped 4.8% to $4,630.59 after earlier plunging nearly 10%. The selloff came as CME Group hiked margin requirements — the cash traders must lock up to hold futures — and investors weighed Kevin Warsh’s nomination to head the Federal Reserve once Chair Jerome Powell steps down. “Gold and silver are on a rollercoaster ride,” said John Meyer at SP Angel. (Reuters)

Evolution Mining traded in Sydney on Wednesday, fluctuating between A$14.59 and A$15.09. Around 4.84 million shares changed hands, and the stock closed under its recent high of A$15.81. (Investing)

Investors are turning their attention to Feb. 11, the date when the company is set to release its FY26 half-year results. Traders want to hear details on production, cash flow, and all-in sustaining costs — a key industry metric covering both ongoing operating expenses and the investments required to maintain mining operations. (Evolution Mining)

The miner announced on Jan. 29 that it will release its financial report and Appendix 4D before the market opens on Feb. 11. A conference call at 10:30 a.m. Sydney time will follow, led by CEO Lawrie Conway and CFO Fran Summerhayes. The company confirmed its FY26 production targets remain unchanged: 710,000 to 780,000 ounces of gold and 70,000 to 80,000 tonnes of copper, with all-in sustaining costs expected between $1,640 and $1,760 per ounce. (Company Announcements)

The gold tape still looks solid on paper. On Monday, J.P. Morgan projected gold prices could hit $6,300 an ounce by the end of 2026, pointing to steady demand from central banks and investors. Deutsche Bank stuck to its $6,000 target for 2026. (Reuters)

The factors driving the stock higher can reverse quickly. A fresh margin surprise, a change in interest rate forecasts, or a sudden drop in geopolitical tensions could push gold down—and drag miners along. This risk looms larger if next week’s earnings reveal rising costs or weaker production.

Stock Market Today

  • Biotech IPO Boom of 2021 Faces Market Reality Four Years On
    February 4, 2026, 1:52 AM EST. The surging biotech initial public offering (IPO) wave in 2021, fueled by pandemic-driven investments, raised $15.6 billion with 99 companies debuting publicly. Experts like Mayo Venture's Audrey Greenberg called it a "masterclass" of scientific enthusiasm matched with financial excess. However, many of these firms now face challenges, with some bankrupt, exposing a gap between financial backing and clinical readiness. Industry leaders attribute this to companies going public too early, without mature data or infrastructure. The sector is now undergoing a "recalibration," focusing on clinical validation and operational discipline to regain investor confidence. Notably, 2025 shows signs of recovery with an increase in late-stage funding rounds and 11 IPOs, including Evommune's $172.5 million offering. Analysts see this as the industry correcting its course rather than collapsing.
Lynas Rare Earths stock jumps 5% on price-floor chatter — what ASX:LYC investors watch next
Previous Story

Lynas Rare Earths stock jumps 5% on price-floor chatter — what ASX:LYC investors watch next

Woodside Energy share price jumps 3% on oil rally — what ASX:WDS investors watch next
Next Story

Woodside Energy share price jumps 3% on oil rally — what ASX:WDS investors watch next

Go toTop